BeStock  
Stocks › Medical Devices › PACB

Pacific Biosciences of California PACB

US equityMarket cap rank #3575Medical Devices
$1.63 −$0.13 (-7.39%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.63 +0.28%
Open$1.69
Prev close$1.76
Day range$1.61 – $1.73
Volume13.69M
Market cap$510.07M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership80.1%+17.09 pts vs. prior quarter
Institutions holding247-13 vs. prior quarter
Insider trades (recent)35 buys / 14 sellsNet buying
ARK fund activity+2,661,217 sh9 recent transactions · last 3 Nov 2026
Short interest17.27% of floatDays to cover 4.1 · as of 30 Oct 2026
Short-sale volume share27.9%5-day average of daily volume

Short-sale volume as % of daily volume

7%17%27%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$8.89M (15 inflow days, 5 outflow days).

Net flow by order size, last 20 sessions

+$9.2MSuper−$318.5KBig−$3.4MMid−$3.7MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.7% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.10.69%
  • BlackRock10.48%
  • ARK Investment Management LLC9.51%
  • SoftBank Group Corp.6.54%
  • The Goldman Sachs Group, Inc.4.52%
  • Vanguard Capital Management, LLC4.23%
  • Goldman Sachs Asset Management, L.P.3.00%
  • Amova Asset Management1.59%

By investor type

  • Mutual Fund54.91%
  • Public Company12.39%
  • Hedge Fund9.41%
  • Private Company2.38%
  • Individual/Insider1.01%
  • VC/PE Fund0.53%
  • Insurance Company0.31%
  • Government Pension Fund0.10%

Reported short interest has risen from 17.18% to 17.27% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +33,214,210 10.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +12,198,503 4.5%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +8,087,546 3.0%
Capricorn Fund Managers Limited Hedge Fund 2026/Q3 +1,932,623 0.6%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +1,162,011 0.5%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +975,306 0.3%
Morgan Stanley Public Company 2026/Q3 +909,831 0.4%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +909,831 0.4%
Jane Street Group, LLC Private Company 2026/Q3 +844,361 0.3%
Barclays PLC Public Company 2026/Q3 +647,641 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +566,903 1.0%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +964,115 0.3%
BlackRock Mutual Fund 2026/Q3 +7,072,121 10.4%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +4,501,600 1.5%
Longaeva Partners L.P. Mutual Fund 2026/Q3 +2,118,231 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
2 Nov 2026 William Meyer Chief Accounting Officer Initial Statement of Beneficial +0 – 44,000
5 Oct 2026 James Gibson Advisor Automatic Disposition -161,815 $3.11 –
5 Oct 2026 James Gibson Advisor Derivative Exercise and Sale -500,000 $3.11 –
16 Aug 2026 Mark Van Oene CEO, President, Director & Interim CFO Open Market Disposition -26,911 $1.13 1,010,972
9 Aug 2026 Mark Van Oene CEO, President, Director & Interim CFO Other Acquisition +489,130 – 1,769,881
9 Aug 2026 Mark Van Oene CEO, President, Director & Interim CFO Other Derivative Acquisition +1,967,888 $1.15 1,967,888
2 Jun 2026 William Ericson Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 Kathy Ordonez Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 John Milligan Independent Chairperson Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 Marshall Mohr Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 Christopher Smith Former Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 Randall Livingston Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
2 Jun 2026 Christopher Gibson Independent Director Other Derivative Acquisition +74,497 $1.58 74,497
2 Jun 2026 Hannah Valantine Independent Director Other Derivative Acquisition +223,492 $1.58 223,492
7 Apr 2026 Christopher Gibson Independent Director Other Acquisition +57,473 – 111,386
7 Apr 2026 Christopher Gibson Independent Director Other Derivative Acquisition +77,842 $1.52 77,842
31 Mar 2026 James Gibson Advisor Open Market Disposition -88,185 $1.37 161,815
2 Mar 2026 Christian O. Henry Senior Business Advisor & Director Open Market Disposition -12,497 $1.51 1,249,042
2 Mar 2026 Christopher Gibson Independent Director Other Acquisition +53,913 – 53,913
2 Mar 2026 Christopher Gibson Independent Director Other Derivative Acquisition +73,087 $1.52 73,087

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 53,681,529 17.3% 4.1
15 Oct 2026 46,933,159 15.1% 2.2
30 Sep 2026 47,224,448 15.2% 3.0
15 Sep 2026 48,892,225 15.7% 10.5
31 Aug 2026 49,578,770 16.0% 6.8
14 Aug 2026 53,412,027 17.2% 6.6

Discussion

No comments yet — be the first to weigh in on PACB.

Sign in to join the discussion.

Scroll to Top